System for electroporation therapy

• US 9,289,606 B2
• Filed: 09/02/2010
• Issued: 03/22/2016
• Est. Priority Date: 09/02/2010
• Status: Active Grant

• Current Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc. (Abbott Laboratories)
• Original Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc. (Abbott Laboratories)
• Inventors: Paul, Saurav, Tegg, Troy T., Byrd, Israel A., Thao, Riki, Puryear, Harry A., Nemec, Linda, Berns, John M.
• Primary Examiner(s): Peffley, Michael
• Assistant Examiner(s): ZINK, AMANDA L
• Application Number:
  US12/874,788
• Publication Number:
  US 20120059255A1
• Time in Patent Office: 2,028 Days
• Field of Search: 606 41- 48
• US Class Current: 1/1
• CPC Class Codes: A61B 18/14 Probes or electrodes therefor
• CPC Class Codes: A61B 2018/0016 Energy applicators arranged in a two- or three dimensional array
• CPC Class Codes: A61N 1/327 for enhancing the absorption properties of tissue, e.g. by electroporation

Abstract

Catheter systems include direction-sensitive, multi-polar tip electrode assemblies for electroporation-mediated therapy, electroporation-induced primary necrosis therapy and electric field-induced apoptosis therapy, including configurations for producing narrow, linear lesions as well as distributed, wide area lesions. A monitoring system for electroporation therapy includes a mechanism for delivering electrochromic dyes to a tissue site as well as a fiber optic arrangement to optically monitor the progress of the therapy as well as to confirm success post-therapy. A fiber optic temperature sensing electrode catheter includes a tip electrode having a cavity whose inner surface is impregnated or coated with thermochromic/thermotropic material that changes color with changes in temperature. An optic fiber/detector arrangement monitors the thermochromic or thermotropic materials, acquiring a light signal and generating an output signal indicative of the spectrum of the light signal. An analyzer determines an electrode temperature based on the detector output and predetermined spectrum versus temperature calibration data.

Claims

1. An electroporation therapy system, comprising:

a device having proximal and distal ends;

an electrode assembly comprising a plurality of electrically isolated electrode elements disposed at said distal end of said device;

a detector coupled to said elements configured to identify which elements have a conduction characteristic indicative of contact with tissue; and

an electroporation generator configured to energize said identified electrode elements in accordance with an electroporation energization strategy, wherein said plurality of electrode elements are arranged in at least a first array disposed on an outer surface of a tubular base wherein said tubular base comprises electrically-insulating material, said array extending along a first path having a shape substantially matching that of said base, an electroporation generator being configured to selectively energize said identified electrode elements of said first array in a bipolar fashion so as to produce a lesion in said tissue having said shape, and wherein said plurality of electrodes are further arranged in a second array disposed on said outer surface of said tubular base, said second array being offset from said first array by a predetermined distance and extending along a second path having said shape, said electroporation generator being further configured to selectively energize said identified electrode elements of said first and second array in a bipolar fashion therebetween so as to produce a lesion in said tissue having said shape and width corresponding to said predetermined distance.

2. The system of claim 1 wherein said electroporation generator is further configured to energize said identified electrode elements in a paired fashion.

3. The system of claim 1 wherein said electroporation generator is further configured to energize said identified electrode elements in a multi-polar fashion.

4. The system of claim 1 further comprising a tissue sensing circuit coupled to said detector wherein said tissue sensing circuit is configured to determine an electrical characteristic associated with one of said electrode elements to determine whether said one electrode element is in contact with tissue.

5. The system of claim 4 wherein said electrical characteristic comprises one of an impedance, a phase angle, and a reactance.

6. The system of claim 5 wherein said tissue sensing circuit includes a tissue sensing signal source for generating an excitation signal used in impedance measurements.

7. The system of claim 5 wherein said tissue sensing circuit includes a complex impedance sensor configured to determine a complex impedance or to resolve a detected impedance into component parts.

8. The system of claim 4 wherein said electrical characteristic comprises an electrical coupling index.

9. The system of claim 4 wherein said detector is configured to receive said characteristic from said tissue sensing circuit and to determine whether a subject electrode element is in tissue contact based on a value of said characteristic and predetermined threshold data.

10. The system of claim 1 wherein said electroporation energizing strategy is chosen based on a therapy selected from the group comprising an electroporation-mediated therapy, an electroporation-induced primary necrosis therapy, and an electric field-induced apoptosis therapy.

11. The system of claim 10 wherein said electroporation generator is configured to produce an electric current that is delivered via said electrode assembly as a pulsed electric field.

12. The system of claim 11 wherein said electroporation energizing strategy includes a pulse magnitude, number, and duration.

13. The system of claim 11 wherein said selected therapy is said electroporation-induced primary necrosis therapy, and wherein said generator is configured to produce said electric current as said pulsed electric field in the form of short-duration direct current (DC) pulses.

14. The system of claim 11 wherein said selected therapy is said electric field-induced apoptosis therapy, and wherein said generator is configured to produce said electric current as said pulsed electric field in the form of extremely short-duration direct current (DC) pulses.

15. The system of claim 1 wherein said first array of electrode elements is distributed contiguously in a linear fashion.

16. The system of claim 1 wherein said first array of electrode elements is distributed contiguously in an arcuate fashion.

17. The system of claim 1 wherein said electrode elements are formed so as to be flush with said outer surface of said tubular base.

18. The system of claim 1 wherein said electrode elements are formed so as to be raised relative to said outer surface of said tubular base.

19. The system of claim 1 wherein said electrode elements comprise at least one of wires, rings, loops and coils.

20. The system of claim 1 wherein said shape comprises one selected from the group comprising a linear shape, an arcuate shape, a L-shape, a question-mark shape and a spiral shape.

21. The system of claim 1 wherein said base has a straight portion having an axis and a distal portion having said shape, at least one of said first array and said second array being said disposed on said base in a plane substantially normal to said axis.